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resolution transmission electron microscopy (HRTEM), and characterised by size and crystal habit (monoclinic or triclinic). Structural analysis was carried out by x ray powder diffraction (XRD) and the proportions of monoclinic to triclinic CPPD were estimated from densitometric measurements of selected key reflections. Results-The mean crystal size, by HRTEM, indicated that the crystals in the acute sample were larger than those in the interval sample. The ratio of monoclinic to triclinic CPPD, whether estimated from their morphological appearance by HRTEM, or from XRD, was greater in the acute than in the interval sample in all nine patients. The total amount of extracted mineral varied, but in every patient the concentration of CPPD per ml of fluid, and the total mineral per joint, were greater in the acute sample than in the interval sample. Conclusion-In this highly selected group of patients, the large numbers of CPPD crystals associated with attacks ofpseudogout included a greater proportion of monoclinic crystals, and larger crystals, than those present when inflammation had subsided. A special, phlogistic population of crystals may exist, originating in different joint tissues, or cleared in a different manner, than the more common populations of smaller crystals with a greater proportion of triclinic CPPD, seen in chronic disease.
(Ann Rheum Dis 1995; 54: 825-830)
The deposition of calcium pyrophosphate dihydrate (CPPD) crystals in joints is a common, age-related phenomenon.' Large deposits can be detected radiographically (chondrocalcinosis (CCA)) and are particularly common in the knee joint, affecting both fibrocartilage menisci and hyaline articular cartilage.2 Crystallographic analysis of these deposits has invariably shown them to contain mixtures of monoclinic and triclinic CPPD crystals of varying sizes.' People with radiographic evidence of CPPD deposits in their knee joints may have no evidence of joint disease; however, there are two well established clinical associations: attacks of acute, self limiting synovitis (pseudogout), and osteoarthritis (OA).4 5 Both in patients with pseudogout and in patients with OA and CCA, CPPD crystals are generally present in the synovial fluid (SF). Several investigators have shown that CPPD crystals can cause inflammation6 7 and it is widely accepted that these crystals cause the inflammation of pseudogout. However, one of the enigmas of the CPPD related disorders, as with other forms of crystal arthropathy, is the fact that the crystals appear to cause attacks of severe synovitis, but are also frequently found free in the joint fluid between attacks, and in patients with OA in whom there is very little synovitis.
There are several possible explanations for this enigma. The crystal load in the joint may be critical, and it has been reported previously that fluids from patients with pseudogout tend to contain more CPPD than those from OA patients.8 Alternatively, either the size or structure of the crystals might be important. The size of CPPD crystals identified in joint tissues and fluids varies considerably, and they are of two types, either monoclinic or triclinic in lattice structure. Using the right hand screw convention for the labelling of axes and interaxial angles of crystals, in the monoclinic system the axial restriction is that a = p = 90 degrees; in the triclinic system there are no symmetry elements. For CPPD, the usual visual expressions of these symmetries (crystal habits) are elongated rod-like for monoclinic (M-)CPPD, and 'squat' rhomboid or cuboid for triclinic (T-)CPPD. It follows from mathematical principles that the surface area:volume ratio of the longer, rod-like M-CPPD is greater than that of T-CPPD. There is some evidence in the literature that smaller crystals can be more phlogistic than larger ones,9 that the structure of crystals, in addition to their surface identity, is important in determining inflammatory response,'0 and that monoclinic CPPD may be more active than the triclinic form." Finally, the protein coating of the crystal might be the dominant factor.'2 13 Rheumatology Unit, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom
In order to examine this, we have studied the synovial fluid crystal load and the size and crystallographic identity of the individual crystals in patients with pseudogout, both during an attack, and at a time in which there was little or no evidence of synovitis.
Patients and methods

PATIENTS
Patients presenting with pseudogout of the knee joint were included in this study. Each patient presented with the sudden onset of pain and swelling of the knee joint, radiographic evidence of CCA and a synovial fluid aspirate which had a high count of polymorphonuclear leucocyte (PMN) cells, and CPPD crystals on polarised light microscopy. The patients were treated by aspiration of as much synovial fluid as possible from the knee, followed by injection of a long acting intra-articular steroid preparation. The patients were followed up over the next six months, and in those patients in whom the affected joint became cool and painless, but showed clinical evidence of an effusion, a second SF sample ('interval' sample) was obtained, the operator again attempting to aspirate as much fluid as possible from the joint. Sequential SF samples suitable for the extraction and analysis of crystals were obtained from nine subjects. In each case, knee radiographs were obtained during the six months of the study and examined by a single observer who recorded the presence of CCA and graded it as minor (1) The total fluid volume was measured and a small aliquot examined for total leucocyte count using a haemocytometer; a differential leucocyte count was performed on an air dried smear. The presence of CPPD-like crystals was confirmed by polarised light microscopy using a Zeiss Axioplan microscope, incorporating a polarised light facility, with first order red quartz plate. The remainder of the sample was processed for extraction of mineral as previously described and validated. '6 Briefly, the fluids were incubated at 37°C with papain 1 mg/ml SF w/v (Sigma P4762), then with fresh sodium hypochlorite solution (final concentration 0/5% v/v). The extracted deposit was washed five times in sterile deionised distilled water, and finally washed in 98% v/v ethanol and dried at 37°C. The small pellet of mineral deposit was then weighed on a Cahn 21 microbalance, before microscopic and analytical examination.
EXAMINATION OF THE EXTRACTED CRYSTALS
Samples of the extracted crystal pellets were examined by polarised light microscopy, high resolution transmission electron microscopy (HRTEM) and x ray diffraction (XRD).
HRTEM was carried out using a JEOL 200CX high resolution transmission electron microscope, operating at 100 KV, and crystals were examined under conditions of minimal illumination. For statistical analysis, the crystals were characterised on the basis of size, and structure (monoclinic and triclinic); the population minimum was 100 crystals and measurements were taken from at least three randomly selected micrographs of each sample.
Structural analysis by XRD used a PW 1010/80 Phillips x ray generator: Cu Kot radiation plus nickel filter, with a Debye-Scherrer powder camera (1 14 83 mm diameter). The relative intensity of the XRD powder lines in any one film was measured by means of a Joyce-Loebl double beam recording microdensitometer, Mk I 1 1 C. Principal XRD reflections were used to distinguish between the two morphological forms of CPPD; these were at d-spacing 8-04 A (intensity I/Il 100) (reflection A) for T-CPPD, and at d-spacing 7-37 A (intensity I/I1 100) (reflection B) and 4-65 A (intensity I/I1 90) (reflection C) for M-CPPD. Because the small quantities of biogenic material available restricted direct quantitative analysis of the composition by XRD, a compromise method was based on densitometric measurements of peak height of the selected reflections (peaks A, B, and C). From these data, estimates of the relative proportion of M-CPPD and T-CPPD could be determined for each sample, with variations in this ratio indicating changes in the crystal population over time.
Results Table 1 shows details of the nine patients. There were five women and four men (mean age 75-4 (range 55-86) years). Seven had evidence of OA, in addition to CCA on the knee radiograph. The interval between collection of the fluid during an acute attack and aspiration of the second (interval) sample varied from four to 24 weeks (mean interval 10 weeks). The volume of SF obtained varied from 3 to 50 ml, and the leucocyte count from 0-1 to 160 X 105/ml SF, but in each of the patients both the total volume of fluid aspirated and the PMNT cell count were greater in the fluid obtained during the acute attack than in the interval sample.
All nine patients had radiological evidence of CCA; there was no apparent relationship between the amount of CCA or the amount of OA change seen on radiographs, and any of the Causal relationship between CPPD crystals and pseudogout 1  81  M  2  0  30  15  10  0-1  2  86  M  2  3  25  9  20  5  3  78  F  1  3  5  5  10  1  4  80  F  2  4  5  4  10  0-1  5  55  F  2  2  50  6  20  0-1  6  75  F  1  3  20  6  20  2  7  69  M  1  0  15  5  27  <1  8  72  M  1  1  5  3  21  <1  9  83  F  1  2  29  21 SF findings (table 1) . Electron micrographs of CPPD crystals extracted from SF from patient 6 illustrate the presence of larger, monoclinic CPPD in the acute sample (fig 1) compared with the interval sample (fig 2) which contains smaller, mainly triclinic CPPD. Figures 3 and 4 Figure 1 Electron micrograph ofcalcium pyrophosphate dihydrate crystals extractedfrom acute synovialfluid sample from patient 6. Totalyield ofcrystals 234 ,g; almost entirely monoclinic (rod shaped), with a mean length of5 6 ,um.
intra-articular steroids,17 but may have persistent small effusions containing CPPD crystals between attacks. These features make these pseudogout patients an ideal group for investigation, and a group of nine patients with classical diagnoses of pseudogout (based upon clinical, radiographic, and SF findings) was selected for this sequential study. It should be noted, however, that this was a highly selected group, because many of those who were successfully treated for pseudogout had either no effusion to aspirate, or too little SF for mineral extraction at the follow up visits. It is also clear that the group selected for study did have some intra-articular inflammation at the time at which the interval sample was aspirated; they had, by definition, an effusion, and the SF analysis showed slightly greater leucocyte counts than are found in normal SF. 18 In spite of these reservations, the strength of the study is that it allowed comparison of two sequential samples from each patient, and that in every /_ ./ Figure 2 Electron micrograph ofcalcium pyrophosphate dihydrate (CPPD) crystals extractedfrom the interval synovialfluid sample from patient 6 . Totalyield of crystals 30 ,ug: a mixture ofM-CPPD (mean length 3-8 ,tm) and T-CPPD (rhomboid/cuboid shaped).
case there was evidence of much more severe inflammation in the acute than in the interval sample.
Our results clearly show that in the acute episode samples there was a greater crystal load, larger crystals, and a greater ratio of monoclinic to triclinic CPPD crystals. Although the number of patients was relatively small, the consistency of the data, which show the same trend in each patient, and the size of the differences noted between the two samples, are impressive. Furthermore, the HRTEM and XRD analyses, both of which were carried out blind.to the clinical data, and each of which used a quite different approach, showed a greater ratio of monoclinic to triclinic crystals in the acute episode SF compared with the interval fluid for every patient. The exact amount of monoclinic and triclinic material in each sample was difficult to compute. The data obtained by HRTEM are based on a morphological assessment of crystal habit. As discussed earlier, the XRD technique used is only semiquantitative; the relative intensities of the reflections for M-and T-CPPD are not related solely to the concentrations of each crystal form within a mixture. However, from measurements of the relative intensities of the key XRD reflections for M-and T-CPPD, an indication of the relative abundance of the two forms was obtained. Changes in this ratio were observed in all nine patients, each acute sample having a greater ratio than the corresponding interval sample. This does not indicate that the concentration of M-CPPD was greater than that of T-CPPD in the acute SF sample, but rather that the ratio shifted in favour of M-CPPD. The morphology of a crystal does not always reflect its structure (although this is usually the case). This fact, together with the semiquantitative nature of XRD analysis, may explain the difference in monoclinic to triclinic ratios reported with each technique, those reported by HRTEM being greater than those recorded from XRD data. In contrast, with CPPD, there was no apparent correlation between the presence of small numbers of coexisting calcium HAP crystals and inflammation.
Previous data on the CPPD crystal loads in SF have also suggested the presence of a greater amount in pseudogout than in less inflammatory conditions.8 However, these data were based on cross sectional rather than longitudinal samples, and used chemical rather than gravimetric methods of analysis. The difference in methodology may explain the discrepancies in the total amount of mineral found. Each acute SF sample contained a greater concentration of CPPD, and a greater total crystal load, than the corresponding interval SF. However, the wide variation in concentration of SF CPPD associated with pseudogout suggests that there is not a clear threshold concentration for CPPD above which an inflammatory response is triggered. A threshold concentration might be associated with some other feature of the crystal population. Crystal habit (monoclinic versus It may be that acute attacks are related to the increased proportion of monoclinic to triclinic CPPD, also observed in inflammatory SF. Given the mechanism described above, our data could be explained in one of two ways. The monoclinic crystals found in pseudogout attacks may be removed more quickly than triclinic crystals. Alternatively, they may be derived from a different type of deposit than the triclinic crystals which predominated in the interval fluids. The possibility of differences in the origins of the crystals, which might also explain the observed size differences, is currently under investigation, by examination of deposits which are formed in different parts of the joint. The third possibility is that M-CPPD crystallises during acute inflammation, but the thermodynamics of aqueous CPPD formation in vitro make this very unlikely. 2' In vitro, M-CPPD converts, over time, to T-CPPD,2' suggesting that it is more soluble.
The reduction in the monoclinic to triclinic ratio and the overall decrease in mean crystal size in the interval samples may then reflect dissolution of the M-form, or phase transformation to the T-form as the acute episode subsides. If both M-and T-CPPD reach the SF from joint tissues in large numbers, thus precipitating an attack ofpseudogout, the more soluble M-CPPD may dissolve or revert to T-CPPD by the time the attack subsides, though it is unlikely that this could happen in vivo in inflammatory SF.
Whatever the reasons for the observed shifts in the proportions of M-CPPD and T-CPPD, our results raise the possibility that monoclinic CPPD crystals are more inflammatory than triclinic CPPD. Certainly, weight for weight, M-CPPD have a greater surface area than T-CPPD, and it is the inorganic surface that mediates interactions with cells and proteins. Indeed, crystal surfaces are known to vary in their ability to bind proteins, including macromolecules associated with cell activation and other mediators of crystal induced inflammation. 2 In conclusion, we have shown that the CPPD crystals associated with attacks of pseudogout include a greater proportion of monoclinic crystals, and larger crystals, than are seen in less inflammatory conditions. This suggests that there may be a special, phlogistic population of CPPD crystals, that originates in different tissues, or is cleared in a different way, than the more common populations of smaller crystals having a greater proportion of T-CPPD. This study was funded by the Arthritis and Rheumatism Council.
